Tuoxin Pharmaceutical plans to invest 10 million yuan to acquire shares in Sanofi

According to the Zhitong Finance APP, Tuoxin Pharmaceutical (301089.SZ) announced that the company will use its own funds of 10 million yuan to increase its investment in Jiangsu Jinsan Biotechnology Co., Ltd. (referred to as "Jinsan Biotechnology"), of which 223,377 yuan will be included in the registered capital, and the remaining amount will be included in the capital reserve. The company has signed the "Investment Agreement on Jiangsu Jinsan Biotechnology Co., Ltd." with Jinsan Biotechnology. After the completion of this transaction, the company will directly hold 1.75% of the equity in Jinsan Biotechnology.

Jinsan Biotechnology is a synthetic biotechnology company that integrates research and development, production, and sales, focusing on the research, production, and industrial application of ergothioneine. Jinsan Biotechnology has successfully achieved the preparation of high-purity ergothioneine through breakthroughs in full-chain technologies such as strain construction, fermentation, purification, and engineering mass production. Its main products include ergothioneine skincare products, oral capsules, and eye wash solutions.

Given the company's technical advantages in process research and development in the fields of chemistry and synthetic biology, the target company has upstream advantages and downstream sales advantages. Currently, the company is actively laying out in the big health product field and has successfully reserved core preparation technologies for products such as ergothioneine. In the future, as the business volume of the target company gradually increases, when the original production capacity or output of the target company is insufficient to meet market demand, the company is expected to better play a role in capacity supplementation to achieve efficient business docking. This external investment is an important measure for the company to extend its production, sales, and research and development industrial chain, which is conducive to achieving horizontal expansion of the industry in the future, enhancing market competitiveness and sustainable profitability, and has positive significance for improving and strengthening the company's production, sales, and research and development layout